Andean Precious Metals (APM) Stock Price, News & Analysis

Company Overview

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: C$1.17 to C$1.28
• 50-Day Range: C$1.07 to C$2.10
• 52-Week Range: C$0.57 to C$2.18
• Volume: 75,863 shs
• Average Volume: 194,112 shs
• Market Capitalization: C$183.71 million
• P/E Ratio: 3.24
• Dividend Yield: N/A
• Price Target: C$1.70
• Consensus Rating: N/A

APM Stock Analysis - Frequently Asked Questions

How have APM shares performed this year?

Andean Precious Metals' stock was trading at C$0.90 on January 1st, 2024. Since then, APM stock has increased by 36.7% and is now trading at C$1.23.
View the best growth stocks for 2024 here.

How do I buy shares of Andean Precious Metals?

Shares of APM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Andean Precious Metals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Andean Precious Metals investors own include Gear Energy (GXE), Erdene Resource Development (ERD), AltaGas (ALA), Bird Construction (BDT), Birchcliff Energy (BIR), Bank of Montreal (BMO) and Bank of Nova Scotia (BNS).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Manufacturing
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: CVE:APM
• CUSIP: N/A
• CIK: N/A
• Web: N/A
• Phone: 852 3953 7700
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$1.70
• High Stock Price Target: C$1.70
• Low Stock Price Target: C$1.70
• Potential Upside/Downside: +38.2%
• Consensus Rating: N/A
• Rating Score (0-4): 0.00
• Research Coverage: 0 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C$0.38
• Trailing P/E Ratio: 3.24
• Forward P/E Ratio: 3.23
• P/E Growth: N/A
• Net Income: C$47.46 million
• Net Margins: 23.75%
• Pretax Margin: N/A
• Return on Equity: 41.08%
• Return on Assets: 4.13%

Debt

• Debt-to-Equity Ratio: 47.01
• Current Ratio: 3.37
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$199.84 million
• Price / Sales: 0.92
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$0.92 per share
• Price / Book: 1.34

Miscellaneous

• Outstanding Shares: 149,360,000
• Free Float: N/A
• Market Cap: C$183.71 million
• Optionable: N/A
• Beta: 1.22